Quotes 5-day view Delayed Nyse
10/15/2020
10/16/2020
10/19/2020
10/20/2020
10/21/2020
Date
52.54(c)
52.32(c)
52.29(c)
52.08(c)
50.58(c)
Last
661 726
1 036 447
776 768
822 424
714 790
Volume
+0.32% -0.42% -0.06% -0.40% -2.88% Change
Sales 2020
1 802 M - -
Net income 2020
326 M - -
Net Debt 2020
1 017 M - -
P/E ratio 2020
36,1x
Yield 2020
-
Sales 2021
2 030 M - -
Net income 2021
430 M - -
Net Debt 2021
634 M - -
P/E ratio 2021
24,8x
Yield 2021
-
Capitalization
11 570 M 11 570 M -
EV / Sales 2020
6,99x
EV / Sales 2021
6,01x
Nbr of Employees
5 200
Free-Float
92,9%
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid).
In 2019, the group developed more than 500 consumable products and automated solutions through its 35 production sites worldwide.
Net sales break down geographically as follows: the United States (43.5%),...
Notations Surperformance© of Qiagen N.V.
Trading Rating : Investor Rating :
All news about QIAGEN N.V.
News in other languages on QIAGEN N.V.
Analyst Recommendations on QIAGEN N.V.
Qiagen chairman quits after Thermo Fisher's takeover bid fails
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends QIAGEN N.V.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
13
Average target price
55,82 $
Last Close Price
50,58 $
Spread / Highest target
30,5%
Spread / Average Target
10,4%
Spread / Lowest Target
-24,9%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
